July 6, 2012 — Boston Scientific Corp. has completed enrollment in the PREVAIL confirmatory study, designed to gain U.S ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
June 15, 2012 —Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety ...
June 11, 2012 — Boehringer Ingelheim Pharmaceuticals Inc. announced that the Pradaxa (dabigatran etexilate mesylate) ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The latest trends and newest cardiac rhythm management technology were highlighted during the biggest electrophysiology ...
May 24, 2012 -- nContact Inc., a provider of epicardial ablation devices, announced that new long-term physician data ...
Diagnostic and Interventional Cardiology Editor Dave Fornell shows some of the most innovative new technology displayed ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
Heart Rhythm Society (HRS) President-Elect Hugh Calkins, M.D., FACC, director, cardiac arrhythmia services and EP lab ...
The current standard-of-care for catheter ablation of atrial fibrillation (AFib) patients includes up to six-hour long ...